6533b830fe1ef96bd12965fd
RESEARCH PRODUCT
Adrenalectomy for solid tumor metastases: Results of a multicenter European study
Mari Fe Candel ArenasEnrique VelosoJosé Nuño Vázquez-garzaPablo MorenoAitor De La Quintana BasarrateJesús Villar-del-moralJose Ignacio RodriguezJosé M. RodríguezThomas J. MusholtJuan Manuel MartosMaría-teresa Gutiérrez RodríguezErnesto Tobalina AguirrezábalIgnacio EscorescaElisabet Bollo ArocenaCarmen González SánchezJean-louis KraimpsJosé Manuel RamiaDavid Scott-coombesKerstin LorenzMaurizio IacoboneIñigo García SanzOscar González LópezIvan PaunovicOscar VidalJosé Miguel Del PinoJaime Vázquez EcharriJesús MartínJoaquín OrtegaMarco PucciniCarlos Domingo-del Pozosubject
Malemedicine.medical_specialtyLung NeoplasmsColorectal cancermedicine.medical_treatmentAdrenal Gland NeoplasmsUrology030230 surgeryDisease-Free Survival03 medical and health sciences0302 clinical medicineRenal cell carcinomaCarcinoma Non-Small-Cell LungmedicineHumansLaparoscopic resectionSolid tumorCarcinoma Renal CellAgedRetrospective StudiesAdrenal glandbusiness.industryAdrenalectomyCancerAdrenalectomyMiddle Agedmedicine.diseaseKidney NeoplasmsConfidence interval3. Good healthSurgeryEuropemedicine.anatomical_structure030220 oncology & carcinogenesisFemaleLaparoscopySurgeryColorectal Neoplasmsbusinessdescription
Background. We assessed the results of adrenalectomy for solid tumor metastases in 317 patients recruited from 30 European centers. Methods. Patients with histologically proven adrenal metastatic disease and undergoing complete removal(s) of the affected gland(s) were eligible. Results. Non-small cell lung cancer (NSCLC) was the most frequent tumor type followed by colorectal and renal cell carcinoma. Adrenal metastases were synchronous (#6 months) in 73 (23%) patients and isolated in 213 (67%). The median disease-free interval was 18.5 months. Laparoscopic resection was used in 46% of patients. Surgery was limited to the adrenal gland in 73% of patients and R0 resection was achieved in 86% of cases. The median overall survival was 29 months (95% confidence interval, 24.69-33.30). The survival rates at 1, 2, 3, and 5 years were 80%, 61%, 42%, and 35%, respectively. Patients with renal cancer showed a median survival of 84 months, patients with NSCLC 26 months, and patients with colorectal cancer 29 months (P = .017). Differences in survival between metachronous and synchronous lesions were also significant (30 vs 23 months; P = .038). Conclusion. Surgical removal of adrenal metastasis is associated with long-term survival in selected patients. (Surgery 2013;154:1215-23.)
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2013-12-01 |